Palisade Bio (PALI) Free Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.73% |
| Dec 31, 2025 | 11.51% |
| Sep 30, 2025 | -95.54% |
| Jun 30, 2025 | 22.12% |
| Mar 31, 2025 | 2.02% |
| Dec 31, 2024 | 24.00% |
| Sep 30, 2024 | 10.46% |
| Jun 30, 2024 | -10.03% |
| Mar 31, 2024 | -15.80% |
| Dec 31, 2023 | -3.16% |
| Sep 30, 2023 | -21.06% |
| Jun 30, 2023 | 37.63% |
| Mar 31, 2023 | -6.33% |
| Dec 31, 2022 | -9.08% |
| Sep 30, 2022 | 6.46% |
| Jun 30, 2022 | 13.66% |
| Mar 31, 2022 | -23.21% |
| Dec 31, 2021 | -11.25% |
| Sep 30, 2021 | 64.44% |
| Jun 30, 2021 | -517.76% |
| Mar 31, 2021 | 19.30% |
| Dec 31, 2020 | -78.46% |
| Sep 30, 2020 | -28.90% |
| Jun 30, 2020 | 59.86% |
| Mar 31, 2020 | 18.12% |
| Dec 31, 2019 | -8.00% |
| Sep 30, 2019 | -15.43% |
| Jun 30, 2019 | 1.34% |
| Mar 31, 2019 | -0.47% |
| Dec 31, 2018 | 0.36% |
| Sep 30, 2018 | 34.06% |
| Jun 30, 2018 | -36.63% |
| Mar 31, 2018 | 19.22% |
| Dec 31, 2017 | 31.22% |
| Sep 30, 2017 | 1.40% |
| Jun 30, 2017 | 24.00% |
| Mar 31, 2017 | -8.72% |
| Dec 31, 2016 | 8.84% |
| Sep 30, 2016 | -22.45% |
| Jun 30, 2016 | -4.35% |
| Mar 31, 2016 | 11.26% |
| Dec 31, 2015 | 28.75% |
| Sep 30, 2015 | -13.43% |
| Jun 30, 2015 | -3.14% |
| Mar 31, 2015 | -34.69% |
| Dec 31, 2014 | -12.39% |
| Sep 30, 2014 | -27.90% |
| Jun 30, 2014 | 13.38% |
| Mar 31, 2014 | -13.76% |
| Dec 31, 2013 | -5.32% |
| Sep 30, 2013 | 29.92% |
| Jun 30, 2013 | -33.76% |
| Mar 31, 2013 | 0.51% |
| Dec 31, 2012 | -77.88% |
| Sep 30, 2012 | 42.44% |
| Jun 30, 2012 | -17.50% |
| Mar 31, 2012 | -17.22% |
| Dec 31, 2011 | 1.49% |
| Sep 30, 2011 | 22.38% |
| Jun 30, 2011 | -0.21% |
| Mar 31, 2011 | 16.42% |
| Dec 31, 2010 | -18.84% |